OBJECTIVES/HYPOTHESIS: To explore neural connectivity changes associated with repetitive transcranial magnetic stimulation (rTMS) to the temporoparietal junction for patients with bothersome tinnitus. STUDY DESIGN: Randomized, double-blind, controlled clinical trial. METHODS:Thirty patients with subjective, nonpulsatile tinnitus for 6 months duration or longer and a score of 36 or greater on the Tinnitus Handicap Inventory completed the study. Participants were randomized to receive either sham or active treatment with rTMS to the temporoparietal junction for either 2 or 4 weeks of therapy. Participants underwent resting state functional connectivity magnetic resonance imaging before therapy and immediately following treatment. Functional connectivity changes between active and sham treatment groups were compared using regions of interest in auditory, default mode, ventral attention, and executive attention networks. RESULTS: Sixteen patients received active rTMS treatment; 14 patients received sham treatment. There were no differences between the active and sham groups in baseline functional connectivity. Neither treatment with rTMS nor sham therapy resulted in statistically significant functional connectivity changes in the examined brain networks. CONCLUSIONS: The analysis did not identify any changes in neural connectivity following treatment in patients with bothersome tinnitus. These results are consistent with our findings of lack of symptom changes previously reported in the same group of patients. Measures of neural connectivity may inform future work using rTMS to better understand the possible benefits of neural stimulation for tinnitus. LEVEL OF EVIDENCE: 1b. Laryngoscope, 126:1201-1206, 2016.
RCT Entities:
OBJECTIVES/HYPOTHESIS: To explore neural connectivity changes associated with repetitive transcranial magnetic stimulation (rTMS) to the temporoparietal junction for patients with bothersome tinnitus. STUDY DESIGN: Randomized, double-blind, controlled clinical trial. METHODS: Thirty patients with subjective, nonpulsatile tinnitus for 6 months duration or longer and a score of 36 or greater on the Tinnitus Handicap Inventory completed the study. Participants were randomized to receive either sham or active treatment with rTMS to the temporoparietal junction for either 2 or 4 weeks of therapy. Participants underwent resting state functional connectivity magnetic resonance imaging before therapy and immediately following treatment. Functional connectivity changes between active and sham treatment groups were compared using regions of interest in auditory, default mode, ventral attention, and executive attention networks. RESULTS: Sixteen patients received active rTMS treatment; 14 patients received sham treatment. There were no differences between the active and sham groups in baseline functional connectivity. Neither treatment with rTMS nor sham therapy resulted in statistically significant functional connectivity changes in the examined brain networks. CONCLUSIONS: The analysis did not identify any changes in neural connectivity following treatment in patients with bothersome tinnitus. These results are consistent with our findings of lack of symptom changes previously reported in the same group of patients. Measures of neural connectivity may inform future work using rTMS to better understand the possible benefits of neural stimulation for tinnitus. LEVEL OF EVIDENCE: 1b. Laryngoscope, 126:1201-1206, 2016.
Authors: Laura Martin; Jeffrey J Borckardt; Scott T Reeves; Heather Frohman; Will Beam; Ziad Nahas; Kevin Johnson; Jarred Younger; Alok Madan; David Patterson; Mark George Journal: Pain Med Date: 2013-05-03 Impact factor: 3.750
Authors: Martin Anders; Jana Dvorakova; Lucie Rathova; Petra Havrankova; Petra Pelcova; Manuela Vaneckova; Robert Jech; Martin Holcat; Zdenek Seidl; Jiri Raboch Journal: Neuro Endocrinol Lett Date: 2010 Impact factor: 0.765
Authors: Carlijn E L Hoekstra; Huib Versnel; Sebastiaan F W Neggers; Marlien E F Niesten; Gijsbert A van Zanten Journal: Audiol Neurootol Date: 2013-10-19 Impact factor: 1.854
Authors: B Langguth; M Landgrebe; E Frank; M Schecklmann; P G Sand; V Vielsmeier; G Hajak; T Kleinjung Journal: World J Biol Psychiatry Date: 2012-08-22 Impact factor: 4.132
Authors: Rhodri Cusack; Alejandro Vicente-Grabovetsky; Daniel J Mitchell; Conor J Wild; Tibor Auer; Annika C Linke; Jonathan E Peelle Journal: Front Neuroinform Date: 2015-01-15 Impact factor: 4.081
Authors: Jay F Piccirillo; Dorina Kallogjeri; Joyce Nicklaus; Andre Wineland; Edward L Spitznagel; Andrei G Vlassenko; Tammie Benzinger; Jose Mathews; Keith S Garcia Journal: JAMA Otolaryngol Head Neck Surg Date: 2013-04 Impact factor: 6.223
Authors: Dorina Kallogjeri; Jay F Piccirillo; Edward Spitznagel; Sandra Hale; Joyce E Nicklaus; Frances Mei Hardin; Joshua S Shimony; Rebecca S Coalson; Bradley L Schlaggar Journal: JAMA Otolaryngol Head Neck Surg Date: 2017-05-01 Impact factor: 6.223
Authors: Martin Formánek; Petra Migaľová; Petra Krulová; Michal Bar; Debora Jančatová; Hana Zakopčanová-Srovnalová; Hana Tomášková; Karol Zeleník; Pavel Komínek Journal: Ann Clin Transl Neurol Date: 2018-06-08 Impact factor: 4.511